Schonfeld Strategic Advisors LLC Reata Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $4.72 Million - $6.28 Million	59,557 Added 108.36%	114,520 $11.7 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $6.41 Million - $19.3 Million	-207,641 Reduced 79.07%	54,963 $5 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $684,346 - $1.3 Million	-30,896 Reduced 10.53%	262,604 $9.98 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $5.7 Million - $10.7 Million	293,500 New	293,500 $7.38 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $958,873 - $1.69 Million	-46,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $1.12 Million - $1.83 Million	46,300 New	46,300 $1.52 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $809,034 - $1.41 Million	-8,650 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $173,662 - $242,770	1,375 Added 18.9%	8,650 $1.35 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $1.28 Million - $2.55 Million	-10,301 Reduced 58.61%	7,275 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $952,706 - $2.78 Million	12,776 Added 266.17%	17,576 $3.59 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $256,536 - $344,700	-3,600 Reduced 42.86%	4,800 $385,000
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $652,848 - $792,540	8,400 New	8,400 $792,000
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $700,000 - $1.06 Million	-35,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $223,900 - $332,700	10,000 Added 40.0%	35,000 $991,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $657,250 - $797,000	25,000	25,000 $778,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.